(Q37190911)

18 August 2017

Comparison of the levels of immunogenicity and safety of Zostavax in adults 50 to 59 years old and in adults 60 years old or older (English)

1 reference

18 August 2017

Santosh C Sutradhar

1

1 reference

18 August 2017

William W B Wang

2

1 reference

18 August 2017

Katia Schlienger

3

1 reference

18 August 2017

Jon E Stek

4

1 reference

18 August 2017

Jin Xu

5

1 reference

18 August 2017

Ivan S F Chan

6

1 reference

18 August 2017

Jeffrey L Silber

7

1 reference

18 August 2017

4 March 2009

1 reference

Clinical and Vaccine Immunology

18 August 2017

1 reference

18 August 2017

16

1 reference

18 August 2017

5

1 reference

18 August 2017

646-652

1 reference

Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

The incidence of herpes zoster in a United States administrative database

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

Clinical practice. Herpes zoster

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

Epidemiology of varicella zoster virus infection in Canada and the United Kingdom

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

Characteristics of patients with herpes zoster on presentation to practitioners in France

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

Herpes zoster in older adults

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

The incidence of herpes zoster

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

The prognosis with postherpetic neuralgia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of age.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

Safety, tolerability, and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects > or =13 years of age.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

Epidemiology of Varicella-Zoster Virus in England and Wales

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681586

Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years

3 September 2018

1 reference

12 December 2020

[Herpes zoster: incidence study among "sentinel" general practitioners]

1 reference

12 December 2020

Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database

1 reference

12 December 2020

1 reference

12 December 2020

Postherpetic neuralgia

1 reference

12 December 2020

Herpes zoster and its complications in Italy: an observational survey

1 reference

12 December 2020

Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older

1 reference

12 December 2020

Identifiers

DOI

10.1128/CVI.00407-08

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19261769

1 reference